Overview
- The company reported statutory net profit of NZ$113.6 million, a 44% decline from the prior year, driven by lower revenue from its China‑label infant milk formula due to late‑year supply disruptions.
- On an adjusted underlying basis a2 Milk recorded profit of NZ$235.8 million, a 7% increase that excludes one‑off items such as Pōkeno acquisition costs.
- Different outlets highlighted alternative headline metrics, with the Australian Financial Review citing net profit after tax of NZ$207.5 million, revenue of NZ$1.975 billion and EBITDA of NZ$284.4 million.
- Management guided to mid‑single‑digit group revenue growth in FY27 and said infant milk formula sales are expected to be broadly similar to FY26 while China demand normalises.
- The company said earnings will be materially weighted to the second half of FY27 as its China distribution recovers and production at the newly acquired Pōkeno plant ramps up, a shift that investors will watch for signs of sustained recovery.